NYSE:ENOVMedical Equipment
Enovis (ENOV) Reaffirmed Guidance And Improved Margins, Is The Stock Still Undervalued?
Enovis (ENOV) drew fresh attention on 6 August 2026 after reaffirming its full year 2026 revenue guidance and releasing second quarter results that showed organic growth, margin improvement, and a smaller net loss.
See our latest analysis for Enovis.
At a share price of $26.61, Enovis has had a mixed run, with a 30 day share price return of 3.34% and a 90 day share price return of 7.38%. However, the 1 year total shareholder return declined 6.43%, suggesting some recent momentum after a...